Medical professionals in Northern Thailand are warning of a critical rise in lung cancer cases, heavily exacerbated by the region’s severe seasonal air pollution. With over 85% of local patients diagnosed in the late stages of the disease, health institutions are urging high-risk populations to adopt proactive screening measures to combat the country’s leading cause of cancer-related mortality.
According to 2025 data from the National Cancer Institute (NCI), Thailand records approximately 140,000 new cancer cases and 83,000 cancer-related deaths annually. Lung cancer alone accounts for 15,022 of those fatalities, or roughly 41 deaths per day, making it the most lethal cancer in the nation.
The PM2.5 factor
The health crisis is notably acute in Chiang Mai and surrounding northern provinces. Annually, between February and April, the region records PM2.5 particulate matter levels that surge significantly above World Health Organization standards. Respiratory specialists note that these microscopic pollutants act as carcinogens, triggering chronic inflammation and cellular mutations that elevate lung cancer risks, even among non-smokers.
To address the growing public health issue, Sriphat Medical Center at Chiang Mai University, in partnership with Johnson & Johnson (Thailand) Limited and AIA Thailand, recently convened a seminar titled “Know Lung Cancer: Detect Early, Treat Precisely.” The initiative aimed to shift the regional medical focus toward early detection, advanced diagnostics, and multidisciplinary treatment protocols.
Early detection and warning signs
Dr. Patraporn Tajaroenmuang, a pulmonologist and critical respiratory care specialist, stated during the event that while smoking and e-cigarette use remain the primary risk factors, prolonged exposure to PM2.5 and genetic predispositions are critical secondary contributors. Because early-stage lung cancer frequently presents without symptoms, she advised individuals to seek immediate medical attention if they experience warning signs such as chronic cough, coughing up blood, unexplained weight loss, or persistent chest pain.
Medical imaging is being positioned as a primary defense. Dr. Chantima Ueatrongchit, President of the Royal College of Radiologists, recommended annual low-dose CT scans to reduce mortality rates through early intervention. She outlined that high-risk demographics—including heavy smokers, individuals aged 50 to 80, those with a family history of the disease, and residents regularly exposed to PM2.5, incense smoke, or asbestos—should undergo routine screening.
Surgical advances and targeted therapies
For cases detected in the early stages, medical facilities in the region are utilizing minimally invasive surgery (MIS). Thoracic surgeon Dr. Somcharoen Saeteng noted that thoracoscopic lung surgery reduces incision size, patient trauma, and recovery times compared to traditional surgical methods.
For more advanced, metastatic cases, oncologist Dr. Songporn Olarattanachai highlighted the integration of targeted therapies. By utilizing genetic testing on cancer cells, oncologists can identify specific abnormalities and deploy customized drug regimens, which helps control the disease and maintain the patient’s quality of life.
The medical strategies are supported by a multidisciplinary framework involving pulmonologists, radiologists, surgeons, and oncologists. Furthermore, addressing the financial barriers to advanced healthcare, Dr. Somsakul Sripisut, Medical Director at AIA Thailand, emphasized the necessity of health insurance planning to ensure broader public access to these critical treatments.
AIS, MHESI, and Chulalongkorn University launch free AI literacy course
51Talk marks 15 years, targets Thai market
